Loading...

APC anti-human CD56 (NCAM) Antibody APC anti-human CD56 (NCAM) Antibody

Pricing & Availability
Clone
HCD56 (See other available formats)
Regulatory Status
RUO
Other Names
Leu-19, NKH1
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
HCD56_APC_020808
Human peripheral blood lymphocytes stained with HCD56 APC
  • HCD56_APC_020808
    Human peripheral blood lymphocytes stained with HCD56 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
318309 25 tests DKK886
Check Availability


Need larger quantities of this item?
Request Bulk Quote
318310 100 tests DKK1866
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD56 is a single transmembrane glycoprotein also known as NCAM (Neural Cell Adhesion Molecule), Leu-19, or NKH1. It is a member of the Ig superfamily. The 140 kD isoform is expressed on NK cells and NK-T cells. CD56 is also expressed in the brain (cerebellum and cortex) and at neuromuscular junctions. Certain large granular lymphocyte (LGL) leukemias, small-cell lung carcinomas, neuronal derived tumors, myelomas, and myeloid leukemias also express CD56. CD56 plays a role in homophilic and heterophilic adhesion via binding to itself or heparin sulfate.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Reported Reactivity
African Green, Baboon, Cynomolgus, Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone HCD56 is not recommended for immunohistochemistry formalin-fixed paraffin-embedded tissue.

Application References
  1. Kishimoto T, et al. Eds. 1997. Leucocyte Typing VI. Garland Publishing Inc. London.
  2. Correia DV, et al. 2011. Blood 118:992. (FC) PubMed
Product Citations
  1. Chen L, et al. 2023. Immunology. 169:204. PubMed
  2. Okano F, et al. 2023. Cancer Res Commun. 3:640. PubMed
  3. Wang T, et al. 2022. Front Immunol. 13:954121. PubMed
  4. Kenney DJ, et al. 2022. Cell Rep. 39:110714. PubMed
  5. Graciliano NG, et al. 2023. Front Immunol. 13:1031248. PubMed
  6. De Hert E, et al. 2022. Int J Mol Sci. 23:. PubMed
  7. Li H, et al. 2018. PLoS Genet. 14:e1007163. PubMed
  8. Junker F, et al. 2021. Cytometry A. 99:832. PubMed
  9. Siebert N, et al. 2014. PLoS One. 9:107692. PubMed
  10. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  11. Davis Z, et al. 2011. J Vis Exp. 49: 2668. PubMed
  12. Pachnio A, et al. 2016. PLoS Pathog. 12: 1005832. PubMed
  13. Shokri MR, et al. 2019. Sci Rep. 9:10007. PubMed
  14. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  15. Miguel Reina‐Campos et al. 2019. Cancer cell. 35(3):385-400 . PubMed
  16. Kan S, et al. 2020. Int J Oncol. 57:1047. PubMed
  17. Abdul-Jawad S, et al. 2021. Cancer Cell. 39(2):257-275.e6. PubMed
  18. Laing AG, et al. 2020. Nat Med. 26:1623. PubMed
  19. Snyder J, et al. 2014. PLoS One. 9:107257. PubMed
  20. Robin J, et al. 2015. J Vis Exp. 95: 52307. PubMed
  21. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  22. Ramendra R, et al. 2021. Front Immunol. 12:694152. PubMed
  23. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  24. Pakula A, et al. 2018. Methods Mol Biol. 1889:01:00. PubMed
  25. Wouters K, et al. 2017. Sci Rep. 7:42665. PubMed
  26. Smith SA, et al. 2019. Front Immunol. 9:3163. PubMed
  27. Palazzo A, et al. 2018. J Immunol. 200:2304. PubMed
  28. Pereira PMR, et al. 2022. Nat Commun. 13:2526. PubMed
  29. Andersen J, et al. 2020. Cell. 183:1913. PubMed
  30. Maas RJ, et al. 2020. Oncoimmunology. 9:1843247. PubMed
  31. Laroni A, et al. 2016. J Autoimmun. 72:8-18. PubMed
  32. Ames E, et al. 2015. J Immunol. 195: 4010 - 4019. PubMed
  33. Rider P, et al. 2015. J Immunol. 195: 1705-1712. PubMed
  34. Rosental B, et al. 2011. J Immunol. 187:5693. PubMed
  35. Al Tanoury Z, et al. 2020. Development. 147:00:00. PubMed
  36. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  37. Vabret N, et al. 2022. iScience. 25:104599. PubMed
  38. Ma Y, et al. 2020. Cell Prolif. 53:e12802. PubMed
  39. Verboven K, et al. 2018. Sci Rep. 8:4677. PubMed
  40. Turaj AH et al. 2017. Cancer cell. 32(6):777-791 . PubMed
  41. Le J, et al. 2020. Immunity. 52(6):1105-1118.e9. PubMed
  42. Yan W, et al. 2020. Biology of Reproduction. . PubMed
  43. Schlecker E, et al. 2014. Cancer Res. 74:3429. PubMed
  44. Taouk G, et al. 2019. Sci Rep. 9:8756. PubMed
  45. Pahl JHW, et al. 2018. Cancer Immunol Res. 0.609027778. PubMed
  46. Molina MS, et al. 2021. Front Immunol. 12:699128. PubMed
  47. Correia DV, et al. 2011. Blood. 118:992. PubMed
  48. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  49. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  50. Al Tanoury Z, et al. 2020. Development. . PubMed
  51. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  52. Walle T, et al. 2022. Sci Adv. 8:eabh4050. PubMed
  53. Strijker JGM, et al. 2021. J Pers Med. 11:. PubMed
  54. Chen L, et al. 2023. Immunology. 169:204. PubMed
  55. Okano F, et al. 2023. Cancer Res Commun. 3:640. PubMed
  56. Wang T, et al. 2022. Front Immunol. 13:954121. PubMed
  57. Kenney DJ, et al. 2022. Cell Rep. 39:110714. PubMed
  58. Graciliano NG, et al. 2023. Front Immunol. 13:1031248. PubMed
  59. De Hert E, et al. 2022. Int J Mol Sci. 23:. PubMed
  60. Li H, et al. 2018. PLoS Genet. 14:e1007163. PubMed
  61. Junker F, et al. 2021. Cytometry A. 99:832. PubMed
  62. Siebert N, et al. 2014. PLoS One. 9:107692. PubMed
  63. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  64. Davis Z, et al. 2011. J Vis Exp. 49: 2668. PubMed
  65. Pachnio A, et al. 2016. PLoS Pathog. 12: 1005832. PubMed
  66. Shokri MR, et al. 2019. Sci Rep. 9:10007. PubMed
  67. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  68. Miguel Reina‐Campos et al. 2019. Cancer cell. 35(3):385-400 . PubMed
  69. Kan S, et al. 2020. Int J Oncol. 57:1047. PubMed
  70. Abdul-Jawad S, et al. 2021. Cancer Cell. 39(2):257-275.e6. PubMed
  71. Laing AG, et al. 2020. Nat Med. 26:1623. PubMed
  72. Snyder J, et al. 2014. PLoS One. 9:107257. PubMed
  73. Robin J, et al. 2015. J Vis Exp. 95: 52307. PubMed
  74. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  75. Ramendra R, et al. 2021. Front Immunol. 12:694152. PubMed
  76. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  77. Pakula A, et al. 2018. Methods Mol Biol. 1889:01:00. PubMed
  78. Wouters K, et al. 2017. Sci Rep. 7:42665. PubMed
  79. Smith SA, et al. 2019. Front Immunol. 9:3163. PubMed
  80. Palazzo A, et al. 2018. J Immunol. 200:2304. PubMed
  81. Pereira PMR, et al. 2022. Nat Commun. 13:2526. PubMed
  82. Andersen J, et al. 2020. Cell. 183:1913. PubMed
  83. Maas RJ, et al. 2020. Oncoimmunology. 9:1843247. PubMed
  84. Laroni A, et al. 2016. J Autoimmun. 72:8-18. PubMed
  85. Ames E, et al. 2015. J Immunol. 195: 4010 - 4019. PubMed
  86. Rider P, et al. 2015. J Immunol. 195: 1705-1712. PubMed
  87. Rosental B, et al. 2011. J Immunol. 187:5693. PubMed
  88. Al Tanoury Z, et al. 2020. Development. 147:00:00. PubMed
  89. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  90. Vabret N, et al. 2022. iScience. 25:104599. PubMed
  91. Ma Y, et al. 2020. Cell Prolif. 53:e12802. PubMed
  92. Verboven K, et al. 2018. Sci Rep. 8:4677. PubMed
  93. Turaj AH et al. 2017. Cancer cell. 32(6):777-791 . PubMed
  94. Le J, et al. 2020. Immunity. 52(6):1105-1118.e9. PubMed
  95. Yan W, et al. 2020. Biology of Reproduction. . PubMed
  96. Schlecker E, et al. 2014. Cancer Res. 74:3429. PubMed
  97. Taouk G, et al. 2019. Sci Rep. 9:8756. PubMed
  98. Pahl JHW, et al. 2018. Cancer Immunol Res. 0.609027778. PubMed
  99. Molina MS, et al. 2021. Front Immunol. 12:699128. PubMed
  100. Correia DV, et al. 2011. Blood. 118:992. PubMed
  101. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  102. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  103. Al Tanoury Z, et al. 2020. Development. . PubMed
  104. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  105. Walle T, et al. 2022. Sci Adv. 8:eabh4050. PubMed
  106. Strijker JGM, et al. 2021. J Pers Med. 11:. PubMed
RRID
AB_604098 (BioLegend Cat. No. 318309)
AB_604106 (BioLegend Cat. No. 318310)

Antigen Details

Structure
Ig superfamily, single transmembrane or GPI-anchored glycoprotein
Distribution

NK cells, T subset, neural tissue, some LGL and myeloid leukemias

Function
Adhesion
Ligand/Receptor
Heparin sulfate
Cell Type
B cells, Leukemia, Mesenchymal Stem Cells, Neurons, NK cells, T cells
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Stem Cells, Synaptic Biology
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Lanier L, et al. 1991. J. Immunol. 146:4421.
2. Hemperly J, et al. 1990. J. Mol. Neurosci. 2:71.
3. Cremer H, et al. 1994. Nature 367:455.

Gene ID
4684 View all products for this Gene ID
UniProt
View information about CD56 on UniProt.org

Related FAQs

There are no FAQs for this product.

Customers Also Purchased

FITC anti-human CD45
Clone: HI30

FITC anti-human CD3
Clone: UCHT1

PE anti-human CD19
Clone: HIB19

PE anti-human CD14
Clone: M5E2

Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

Pricing & Availability
Clone
HCD56 (See other available formats)
Regulatory Status
RUO
Other Names
Leu-19, NKH1
Isotype
Mouse IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
HCD56_APC_020808
Human peripheral blood lymphocytes stained with HCD56 APC
  • HCD56_APC_020808
    Human peripheral blood lymphocytes stained with HCD56 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
318309 25 tests DKK886
Check Availability


Need larger quantities of this item?
Request Bulk Quote
318310 100 tests DKK1866
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD56 is a single transmembrane glycoprotein also known as NCAM (Neural Cell Adhesion Molecule), Leu-19, or NKH1. It is a member of the Ig superfamily. The 140 kD isoform is expressed on NK cells and NK-T cells. CD56 is also expressed in the brain (cerebellum and cortex) and at neuromuscular junctions. Certain large granular lymphocyte (LGL) leukemias, small-cell lung carcinomas, neuronal derived tumors, myelomas, and myeloid leukemias also express CD56. CD56 plays a role in homophilic and heterophilic adhesion via binding to itself or heparin sulfate.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human
Reported Reactivity
African Green, Baboon, Cynomolgus, Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone HCD56 is not recommended for immunohistochemistry formalin-fixed paraffin-embedded tissue.

Application References
  1. Kishimoto T, et al. Eds. 1997. Leucocyte Typing VI. Garland Publishing Inc. London.
  2. Correia DV, et al. 2011. Blood 118:992. (FC) PubMed
Product Citations
  1. Chen L, et al. 2023. Immunology. 169:204. PubMed
  2. Okano F, et al. 2023. Cancer Res Commun. 3:640. PubMed
  3. Wang T, et al. 2022. Front Immunol. 13:954121. PubMed
  4. Kenney DJ, et al. 2022. Cell Rep. 39:110714. PubMed
  5. Graciliano NG, et al. 2023. Front Immunol. 13:1031248. PubMed
  6. De Hert E, et al. 2022. Int J Mol Sci. 23:. PubMed
  7. Li H, et al. 2018. PLoS Genet. 14:e1007163. PubMed
  8. Junker F, et al. 2021. Cytometry A. 99:832. PubMed
  9. Siebert N, et al. 2014. PLoS One. 9:107692. PubMed
  10. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  11. Davis Z, et al. 2011. J Vis Exp. 49: 2668. PubMed
  12. Pachnio A, et al. 2016. PLoS Pathog. 12: 1005832. PubMed
  13. Shokri MR, et al. 2019. Sci Rep. 9:10007. PubMed
  14. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  15. Miguel Reina‐Campos et al. 2019. Cancer cell. 35(3):385-400 . PubMed
  16. Kan S, et al. 2020. Int J Oncol. 57:1047. PubMed
  17. Abdul-Jawad S, et al. 2021. Cancer Cell. 39(2):257-275.e6. PubMed
  18. Laing AG, et al. 2020. Nat Med. 26:1623. PubMed
  19. Snyder J, et al. 2014. PLoS One. 9:107257. PubMed
  20. Robin J, et al. 2015. J Vis Exp. 95: 52307. PubMed
  21. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  22. Ramendra R, et al. 2021. Front Immunol. 12:694152. PubMed
  23. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  24. Pakula A, et al. 2018. Methods Mol Biol. 1889:01:00. PubMed
  25. Wouters K, et al. 2017. Sci Rep. 7:42665. PubMed
  26. Smith SA, et al. 2019. Front Immunol. 9:3163. PubMed
  27. Palazzo A, et al. 2018. J Immunol. 200:2304. PubMed
  28. Pereira PMR, et al. 2022. Nat Commun. 13:2526. PubMed
  29. Andersen J, et al. 2020. Cell. 183:1913. PubMed
  30. Maas RJ, et al. 2020. Oncoimmunology. 9:1843247. PubMed
  31. Laroni A, et al. 2016. J Autoimmun. 72:8-18. PubMed
  32. Ames E, et al. 2015. J Immunol. 195: 4010 - 4019. PubMed
  33. Rider P, et al. 2015. J Immunol. 195: 1705-1712. PubMed
  34. Rosental B, et al. 2011. J Immunol. 187:5693. PubMed
  35. Al Tanoury Z, et al. 2020. Development. 147:00:00. PubMed
  36. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  37. Vabret N, et al. 2022. iScience. 25:104599. PubMed
  38. Ma Y, et al. 2020. Cell Prolif. 53:e12802. PubMed
  39. Verboven K, et al. 2018. Sci Rep. 8:4677. PubMed
  40. Turaj AH et al. 2017. Cancer cell. 32(6):777-791 . PubMed
  41. Le J, et al. 2020. Immunity. 52(6):1105-1118.e9. PubMed
  42. Yan W, et al. 2020. Biology of Reproduction. . PubMed
  43. Schlecker E, et al. 2014. Cancer Res. 74:3429. PubMed
  44. Taouk G, et al. 2019. Sci Rep. 9:8756. PubMed
  45. Pahl JHW, et al. 2018. Cancer Immunol Res. 0.609027778. PubMed
  46. Molina MS, et al. 2021. Front Immunol. 12:699128. PubMed
  47. Correia DV, et al. 2011. Blood. 118:992. PubMed
  48. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  49. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  50. Al Tanoury Z, et al. 2020. Development. . PubMed
  51. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  52. Walle T, et al. 2022. Sci Adv. 8:eabh4050. PubMed
  53. Strijker JGM, et al. 2021. J Pers Med. 11:. PubMed
  54. Chen L, et al. 2023. Immunology. 169:204. PubMed
  55. Okano F, et al. 2023. Cancer Res Commun. 3:640. PubMed
  56. Wang T, et al. 2022. Front Immunol. 13:954121. PubMed
  57. Kenney DJ, et al. 2022. Cell Rep. 39:110714. PubMed
  58. Graciliano NG, et al. 2023. Front Immunol. 13:1031248. PubMed
  59. De Hert E, et al. 2022. Int J Mol Sci. 23:. PubMed
  60. Li H, et al. 2018. PLoS Genet. 14:e1007163. PubMed
  61. Junker F, et al. 2021. Cytometry A. 99:832. PubMed
  62. Siebert N, et al. 2014. PLoS One. 9:107692. PubMed
  63. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  64. Davis Z, et al. 2011. J Vis Exp. 49: 2668. PubMed
  65. Pachnio A, et al. 2016. PLoS Pathog. 12: 1005832. PubMed
  66. Shokri MR, et al. 2019. Sci Rep. 9:10007. PubMed
  67. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  68. Miguel Reina‐Campos et al. 2019. Cancer cell. 35(3):385-400 . PubMed
  69. Kan S, et al. 2020. Int J Oncol. 57:1047. PubMed
  70. Abdul-Jawad S, et al. 2021. Cancer Cell. 39(2):257-275.e6. PubMed
  71. Laing AG, et al. 2020. Nat Med. 26:1623. PubMed
  72. Snyder J, et al. 2014. PLoS One. 9:107257. PubMed
  73. Robin J, et al. 2015. J Vis Exp. 95: 52307. PubMed
  74. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  75. Ramendra R, et al. 2021. Front Immunol. 12:694152. PubMed
  76. Huang Y, et al. 2020. FASEB J. 34:1768. PubMed
  77. Pakula A, et al. 2018. Methods Mol Biol. 1889:01:00. PubMed
  78. Wouters K, et al. 2017. Sci Rep. 7:42665. PubMed
  79. Smith SA, et al. 2019. Front Immunol. 9:3163. PubMed
  80. Palazzo A, et al. 2018. J Immunol. 200:2304. PubMed
  81. Pereira PMR, et al. 2022. Nat Commun. 13:2526. PubMed
  82. Andersen J, et al. 2020. Cell. 183:1913. PubMed
  83. Maas RJ, et al. 2020. Oncoimmunology. 9:1843247. PubMed
  84. Laroni A, et al. 2016. J Autoimmun. 72:8-18. PubMed
  85. Ames E, et al. 2015. J Immunol. 195: 4010 - 4019. PubMed
  86. Rider P, et al. 2015. J Immunol. 195: 1705-1712. PubMed
  87. Rosental B, et al. 2011. J Immunol. 187:5693. PubMed
  88. Al Tanoury Z, et al. 2020. Development. 147:00:00. PubMed
  89. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  90. Vabret N, et al. 2022. iScience. 25:104599. PubMed
  91. Ma Y, et al. 2020. Cell Prolif. 53:e12802. PubMed
  92. Verboven K, et al. 2018. Sci Rep. 8:4677. PubMed
  93. Turaj AH et al. 2017. Cancer cell. 32(6):777-791 . PubMed
  94. Le J, et al. 2020. Immunity. 52(6):1105-1118.e9. PubMed
  95. Yan W, et al. 2020. Biology of Reproduction. . PubMed
  96. Schlecker E, et al. 2014. Cancer Res. 74:3429. PubMed
  97. Taouk G, et al. 2019. Sci Rep. 9:8756. PubMed
  98. Pahl JHW, et al. 2018. Cancer Immunol Res. 0.609027778. PubMed
  99. Molina MS, et al. 2021. Front Immunol. 12:699128. PubMed
  100. Correia DV, et al. 2011. Blood. 118:992. PubMed
  101. Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed
  102. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  103. Al Tanoury Z, et al. 2020. Development. . PubMed
  104. Yang Zhou J, et al. 2022. Front Immunol. 13:898473. PubMed
  105. Walle T, et al. 2022. Sci Adv. 8:eabh4050. PubMed
  106. Strijker JGM, et al. 2021. J Pers Med. 11:. PubMed
RRID
AB_604098 (BioLegend Cat. No. 318309)
AB_604106 (BioLegend Cat. No. 318310)

Antigen Details

Structure
Ig superfamily, single transmembrane or GPI-anchored glycoprotein
Distribution

NK cells, T subset, neural tissue, some LGL and myeloid leukemias

Function
Adhesion
Ligand/Receptor
Heparin sulfate
Cell Type
B cells, Leukemia, Mesenchymal Stem Cells, Neurons, NK cells, T cells
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Stem Cells, Synaptic Biology
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Lanier L, et al. 1991. J. Immunol. 146:4421.
2. Hemperly J, et al. 1990. J. Mol. Neurosci. 2:71.
3. Cremer H, et al. 1994. Nature 367:455.

Gene ID
4684 View all products for this Gene ID
UniProt
View information about CD56 on UniProt.org

Customers Also Purchased

FITC anti-human CD45
Clone: HI30

FITC anti-human CD3
Clone: UCHT1

PE anti-human CD19
Clone: HIB19

PE anti-human CD14
Clone: M5E2

Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account